Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.6700
-0.0100 (-1.47%)
Oct 22, 2025, 10:49 AM EDT
-1.47% (1Y)
| Market Cap | 34.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.09M |
| Shares Out | 51.84M |
| EPS (ttm) | -0.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,100 |
| Average Volume | 14,252 |
| Open | 0.6700 |
| Previous Close | 0.6800 |
| Day's Range | 0.6700 - 0.6700 |
| 52-Week Range | 0.5100 - 0.8800 |
| Beta | 0.65 |
| RSI | 35.92 |
| Earnings Date | Nov 17, 2025 |